BOSTON SCIENTIFIC CORPORATION REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)
|
Back to Search Results |
|
Model Number D2201 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Obstruction/Occlusion (2422); Dysuria (2684)
|
Event Date 10/05/2023 |
Event Type
Injury
|
Event Description
|
It was reported that the patient underwent a water vapor therapy procedure under anesthesia.The procedure was completed without patient complications.Then, 86 days after the procedure, the patient presented a prostate obstruction and dysuria caused by a prominent middle lobe protruding into the bladder, diagnosed through a flexible urinary fibroscopy.This patient was treated with dutasteride and tamsulosin medication, however the event is still on going.This event is possibly related to the water vapor therapy procedure.
|
|
Event Description
|
It was reported that the patient underwent a water vapor therapy procedure under anesthesia.The procedure was completed without patient complications.Then, 86 days after the procedure, the patient presented a prostate obstruction and dysuria caused by a prominent middle lobe protruding into the bladder, diagnosed through a flexible urinary fibroscopy.This patient was treated with dutasteride and tamsulosin medication, however the event is still on going.The treatment plan for the patient will include an exclusive enucleation of the middle lobe.This event is possibly related to the water vapor therapy procedure.
|
|
Manufacturer Narrative
|
The complaint component has not been returned; therefore, no physical or visual analysis of the product could be performed.A review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.The data reasonably suggest that the clinical event of a prominent middle lobe protruding into the bladder causing dysuria not related to the device, possibly related to the procedure with dutasteride and tamsulosin medication treatment are anticipated in nature and severity as per instructions for use and hazard analysis.In addition, the reported patient symptoms of dysuria and obstruction are a known inherent risk of device use as documented in the product instructions for use.
|
|
Search Alerts/Recalls
|
|
|